Losartan Potassium (DuP 753) - ≥99%, high purity , Type-1 angiotensin II receptor antagonist, CAS No.124750-99-8, Type-1 angiotensin II receptor antagonist

  • ≥99%
Item Number
L129227
Grouped product items
SKUSizeAvailabilityPrice Qty
L129227-1g
1g
In stock
$64.90
L129227-5g
5g
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$142.90
L129227-10g
10g
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$257.90
L129227-25g
25g
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$579.90
L129227-100g
100g
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$2,084.90
L129227-500g
500g
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$9,382.90

Selective non-peptide angiotensin II AT 1 receptor antagonist

Basic Description

SynonymsDTXSID70196363 | Losartan potassium (USAN:USP) | LOSARTAN POTASSIUM [EP MONOGRAPH] | Monopotassium Salt, Losartan | Presartan-50 | LOSARTAN POTASSIUM COMPONENT OF HYZAAR | UNII-3ST302B24A | LOSARTAN MONOPOTASSIUM SALT [MI] | LOSARTAN POTASSIUM (USP MONOGR
Specifications & Purity≥99%
Biochemical and Physiological MechanismsLosartan Potassium is a specific antagonist of the angiotensin II receptor subtype AT1. Antagonism of the AT1 receptor and interference of association between AT1 and angiotensin II produces vasodilation and reduction of hypertension. This antagonism has
Shipped InNormal
Action TypeANTAGONIST
Mechanism of actionType-1 angiotensin II receptor antagonist
NoteWherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
Product Description

Losartan potassium is a new drug used for hypertension. It is nonpeptide angiotensin II (AII) receptor antagonist.
Losartan potassium is nonpeptide angiotensin II (AII) receptor antagonist and is orally active. It belongs to a new class of drugs introduced for clinical trials to treat hypertension.
A specific antagonist of the AT1 receptor with significant downstream effects.

Associated Targets(Human)

AGTR1 Tclin Type-1 angiotensin II receptor (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
AGTR1 Tclin Type-1 angiotensin II receptor (5176 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Homo sapiens (32628 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABCC2 Tchem Canalicular multispecific organic anion transporter 1 (1191 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABCB11 Tchem Bile salt export pump (2311 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABCC3 Tbio Canalicular multispecific organic anion transporter 2 (718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SMAD3 Tchem Mothers against decapentaplegic homolog 3 (68039 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CBX1 Tbio Chromobox protein homolog 1 (92434 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABCC4 Tchem Multidrug resistance-associated protein 4 (785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE3A Tclin Phosphodiesterase 3 (1749 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RAN Tchem GTP-binding nuclear protein Ran/Importin subunit beta-1/Snurportin-1 (21853 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Agtr2 Angiotensin II type 2 (AT-2) receptor (803 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ampC Beta-lactamase AmpC (62480 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Agtr1b Type-1B angiotensin II receptor (525 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AGTR1 Angiotensin II type 1a (AT-1a) receptor (440 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pseudomonas aeruginosa (123386 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Klebsiella pneumoniae (43867 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Acinetobacter baumannii (41033 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Escherichia coli (133304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cryptococcus neoformans (21258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Candida albicans (78123 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Oryctolagus cuniculus (11301 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rep Replicase polyprotein 1ab (378 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
fba Putative fructose-1,6-bisphosphate aldolase (15559 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Agtr1b Angiotensin II receptor (1735 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Agtr1b Angiotensin II receptor (AT-1) type-1 (1480 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MC3T3-E1 (421 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Names and Identifiers

IUPAC Name potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol
INCHI InChI=1S/C22H22ClN6O.K/c1-2-3-8-20-24-21(23)19(14-30)29(20)13-15-9-11-16(12-10-15)17-6-4-5-7-18(17)22-25-27-28-26-22;/h4-7,9-12,30H,2-3,8,13-14H2,1H3;/q-1;+1
InChi Key OXCMYAYHXIHQOA-UHFFFAOYSA-N
Canonical SMILES CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)CO)Cl.[K+]
Isomeric SMILES CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)CO)Cl.[K+]
RTECS NI6755100
PubChem CID 11751549
Molecular Weight 461
Beilstein 5845770
Reaxy-Rn 5900704

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

9 results found

Lot NumberCertificate TypeDateItem
F2206183Certificate of AnalysisMar 19, 2024 L129227
F2206186Certificate of AnalysisMar 19, 2024 L129227
F2206270Certificate of AnalysisMar 19, 2024 L129227
F2206271Certificate of AnalysisMar 19, 2024 L129227
F2206346Certificate of AnalysisMar 19, 2024 L129227
D2126270Certificate of AnalysisFeb 09, 2023 L129227
D2126269Certificate of AnalysisFeb 09, 2023 L129227
D2126271Certificate of AnalysisFeb 09, 2023 L129227
F1515019Certificate of AnalysisJan 17, 2023 L129227

Chemical and Physical Properties

SolubilitySoluble in water (>500 mg/ml), PBS (pH 7.2) (≥10 mg/ml), ethanol (≥20 mg/ml), DMSO (100 mM), and DMF (≥20 mg/ml).
SensitivityMoisture sensitive
Melt Point(°C)183.5 - 184.5 °C

Safety and Hazards(GHS)

RTECS NI6755100
Reaxy-Rn 5900704
Merck Index 5583

Related Documents

Citations of This Product

1. Qinglin Wang, Hao Yuan, Xinyue Pan, Yiling Yang, Xiaosong Ma, Yahui Guo.  (2024)  Synthesis of silver nanoclusters using a double-stranded DNA template and its application for captopril detection.  JOURNAL OF FOOD COMPOSITION AND ANALYSIS,  126  (17): (105825).  [PMID:17580304] [10.1016/j.jfca.2023.105825]
2. Shasha Liu, Ruohan Cheng, Hui He, Kunming Ding, Rongmi Zhang, Yuanyuan Chai, Qinwei Yu, Xin Huang, Luyong Zhang, Zhenzhou Jiang.  (2023)  8-methoxypsoralen protects against acetaminophen-induced liver injury by antagonising Cyp2e1 in mice.  ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS,  741  (109617).  [PMID:37121295] [10.1016/j.abb.2023.109617]
3. Chang Li, Benzhi Ju, Shufen Zhang.  (2023)  Fully bio-based hydroxy ester vitrimer synthesized by crosslinking epoxidized soybean oil with doubly esterified starch.  CARBOHYDRATE POLYMERS,  302  (120442).  [PMID:36604037] [10.1016/j.carbpol.2022.120442]
4. Sun Zhiping, He Lingli, Yang Qingqing, Zhang Haizhi, Xu Weiren, Qin Xinguang, Liu Gang, Hu Zhongze, Zhang Luyong, Liu Changxiao.  (2022)  Study on the Effect of Three CYP2C9 Variants on Drug–Drug Interaction Related to Six Drugs In Vitro by LC–MS/MS Method.  CHROMATOGRAPHIA,  85  (3): (221-231).  [PMID:] [10.1007/s10337-021-04126-8]
5. Yuanyuan Chai, Yunxia Xu, Ziyin Xia, Xin Huang, Luyong Zhang, Zhenzhou Jiang.  (2021)  Study on the effects of Zhuanggu Guanjie Pill, a modern Chinese medicine formula, on the activities and mRNA expression of seven CYP isozymes in rats.  JOURNAL OF ETHNOPHARMACOLOGY,  281  (114521).  [PMID:34390794] [10.1016/j.jep.2021.114521]
6. Lin Yue, Meihong Zheng, Min Wang, Imran Mahmood Khan, Bin Wang, Xiaoyuan Ma, Chifang Peng, Zhouping Wang, Wenshui Xia.  (2021)  A general strategy to synthesis chitosan oligosaccharide-O-Terpenol derivatives with antibacterial properties.  CARBOHYDRATE RESEARCH,  503  (108315).  [PMID:33865180] [10.1016/j.carres.2021.108315]

References

1. Hu B et al..  (2018)  Angiotensin II facilitates GABAergic neurotransmission at postsynaptic sites in rat amygdala neurons..  Neuropharmacology,  133  (334-344).  [PMID:29447844]
2. Oliveira PA et al..  (2017)  Angiotensin II type 1/adenosine A 2A receptor oligomers: a novel target for tardive dyskinesia..  Sci Rep,  (1857).  [PMID:28500295]
3. Ageeva LV et al..  (2018)  Data supporting that adipose-derived mesenchymal stem/stromal cells express angiotensin II receptors in situ and in vitro..  Data Brief,  16  (327-333).  [PMID:29234689]
4. Sysoeva VY et al..  (2017)  Local angiotensin II promotes adipogenic differentiation of human adipose tissue mesenchymal stem cells through type 2 angiotensin receptor..  Stem Cell Res,  25  (115-122).  [PMID:29127873]
5. Qinglin Wang, Hao Yuan, Xinyue Pan, Yiling Yang, Xiaosong Ma, Yahui Guo.  (2024)  Synthesis of silver nanoclusters using a double-stranded DNA template and its application for captopril detection.  JOURNAL OF FOOD COMPOSITION AND ANALYSIS,  126  (17): (105825).  [PMID:17580304] [10.1016/j.jfca.2023.105825]
6. Shasha Liu, Ruohan Cheng, Hui He, Kunming Ding, Rongmi Zhang, Yuanyuan Chai, Qinwei Yu, Xin Huang, Luyong Zhang, Zhenzhou Jiang.  (2023)  8-methoxypsoralen protects against acetaminophen-induced liver injury by antagonising Cyp2e1 in mice.  ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS,  741  (109617).  [PMID:37121295] [10.1016/j.abb.2023.109617]
7. Chang Li, Benzhi Ju, Shufen Zhang.  (2023)  Fully bio-based hydroxy ester vitrimer synthesized by crosslinking epoxidized soybean oil with doubly esterified starch.  CARBOHYDRATE POLYMERS,  302  (120442).  [PMID:36604037] [10.1016/j.carbpol.2022.120442]
8. Sun Zhiping, He Lingli, Yang Qingqing, Zhang Haizhi, Xu Weiren, Qin Xinguang, Liu Gang, Hu Zhongze, Zhang Luyong, Liu Changxiao.  (2022)  Study on the Effect of Three CYP2C9 Variants on Drug–Drug Interaction Related to Six Drugs In Vitro by LC–MS/MS Method.  CHROMATOGRAPHIA,  85  (3): (221-231).  [PMID:] [10.1007/s10337-021-04126-8]
9. Yuanyuan Chai, Yunxia Xu, Ziyin Xia, Xin Huang, Luyong Zhang, Zhenzhou Jiang.  (2021)  Study on the effects of Zhuanggu Guanjie Pill, a modern Chinese medicine formula, on the activities and mRNA expression of seven CYP isozymes in rats.  JOURNAL OF ETHNOPHARMACOLOGY,  281  (114521).  [PMID:34390794] [10.1016/j.jep.2021.114521]
10. Lin Yue, Meihong Zheng, Min Wang, Imran Mahmood Khan, Bin Wang, Xiaoyuan Ma, Chifang Peng, Zhouping Wang, Wenshui Xia.  (2021)  A general strategy to synthesis chitosan oligosaccharide-O-Terpenol derivatives with antibacterial properties.  CARBOHYDRATE RESEARCH,  503  (108315).  [PMID:33865180] [10.1016/j.carres.2021.108315]

Solution Calculators